tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Charles Zhu, 7 are a BUY (100%).
Analyst Charles Zhu, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 47.62% that have a potential upside of 22.53% achieved within 102 days. Previously, Charles Zhu worked at LIFESCI.
Charles Zhu’s has documented 45 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TNGX, Tango Therapeutics at 24-Oct-2025.
Analyst best performing recommendations are on TNGX (TANGO THERAPEUTICS).
The best stock recommendation documented was for TNGX (TANGO THERAPEUTICS) at 9/7/2021. The price target of $16 was fulfilled within 9 days with a profit of $1.15 (7.74%) receiving and performance score of 8.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Sep-2021
$3
$0.35 (13.21%)
$5
8 months 16 days ago
(28-Oct-2025)
0/19 (0%)
$1.21 (67.60%)
Buy Since 25-Sep-2023
$4
$1.35 (50.94%)
$12
1 years 7 months 1 days ago
(13-Dec-2024)
1/8 (12.5%)
$2.23 (125.99%)
9
Buy Since 14-Jul-2020
1 years 9 months 13 days ago
(01-Oct-2024)
2/6 (33.33%)
$19.91 (391.16%)
141
Buy Since 18-Mar-2022
$28
$25.35 (956.60%)
3 years 2 months 4 days ago
(10-May-2023)
0/2 (0%)
$17.42 (164.65%)
$14
$11.35 (428.30%)
$15
3 years 4 months 17 days ago
(27-Feb-2023)
2/6 (33.33%)
$3.45 (32.70%)
85
What Year was the first public recommendation made by Charles Zhu?
